Douglas Carr insider trades
Open-market stock purchases and sales by Douglas Carr, SVP Finance & Operations at Century Therapeutics, Inc, from SEC Form 4 filings since Jan 25, 2022.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Sep 14, 2026 | IPSC Century Therapeutics, Inc | Sold | $3.2K |
| Sep 8, 2026 | IPSC Century Therapeutics, Inc | Sold | $521 |
| Aug 3, 2026 | IPSC Century Therapeutics, Inc | Sold | $544 |
| Jun 12, 2026 | IPSC Century Therapeutics, Inc | Sold | $3.7K |
| Jun 8, 2026 | IPSC Century Therapeutics, Inc | Sold | $526 |
| May 4, 2026 | IPSC Century Therapeutics, Inc | Sold | $618 |
| Mar 12, 2026 | IPSC Century Therapeutics, Inc | Sold | $18K |
| Mar 9, 2026 | IPSC Century Therapeutics, Inc | Sold | $626 |
| Feb 3, 2026 | IPSC Century Therapeutics, Inc | Sold | $589 |
| Feb 2, 2026 | IPSC Century Therapeutics, Inc | Bought (not open market) | — |
| Feb 2, 2026 | IPSC Century Therapeutics, Inc | Bought (not open market) | — |
| Dec 8, 2025 | IPSC Century Therapeutics, Inc | Sold | $137 |
| Nov 3, 2025 | IPSC Century Therapeutics, Inc | Sold | $171 |
Companies traded
- IPSC Century Therapeutics, Inc: 22 sales, last Sep 14, 2026